Delek Group’s Zimmer Biomet ZBH Stock Holding History

Delek Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-139,050	Closed	-$17.2M	–	248
2019 Q1	$17.2M	Buy	139,050 +97,850	+238%	+$11.1M	0.71%	56
2018 Q4	$4.27M	Buy	+41,200	New	+$4.63M	0.19%	130

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Delek Group's ZBH Position: Q2 2019 in Review

Delek Group sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 139,050 shares — an estimated $17.2M sold.

Delek Group first reported a position in ZBH in Q4 2018 and held it in 2 quarters. The position peaked at $17.2M in Q1 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Delek Group reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Delek Group sold 139,050 Zimmer Biomet shares in Q2 2019, an estimated $17.2M.
Delek Group first reported a position in Zimmer Biomet in Q4 2018 and held it in 2 quarters.
Delek Group's Zimmer Biomet position peaked at $17.2M in Q1 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.